Publication:
L-Carnitine ameliorates methotrexate-induced oxidative organ injury and inhibits leukocyte death

Simple item page
dc.contributor.authorYEGEN, BERRAK
dc.contributor.authorsSener, G; Eksioglu-Demiralp, E; Cetiner, M; Ercan, F; Sirvanci, S; Gedik, N; Yegen, BC
dc.date.accessioned2022-03-12T17:19:50Z
dc.date.available2022-03-12T17:19:50Z
dc.date.issued2006
dc.description.abstractMethotrexate (MTX), a folic acid antagonist widely used for the treatment of a variety of tumors and inflammatory diseases, affects normal tissues that have a high rate of proliferation, including the hematopoietic cells of the bone marrow and the gastrointestinal mucosal cells. To elucidate the role of free radicals and leukocytes in MTX-induced oxidative organ damage and the putative protective effect of L-carnitine (L-Car), Wistar albino rats were administered a single dose of MTX (20 mg/kg) followed by either saline or L-Car (500 mg/kg) for 5 days. After decapitation of the rats, trunk blood was obtained, and the ileum, liver, and kidney were removed for histological examination and for the measurement of malondialdehyde (MDA) and glutathione (GSH) levels, myeloperoxidase (MPO) activity, and collagen content. Our results showed that MTX administration increased the MDA and MPO activities and collagen content and decreased GSH levels in all tissues, while these alterations were reversed in L-Car-treated group. The elevated serum TNF-alpha level observed following MTX treatment was depressed with L-Car. The oxidative burst of neutrophils stimulated by Annexin V was reduced in the saline-treated MTX group, while L-Car abolished this inhibition. Similarly, flow cytometric measurements revealed that leukocyte apoptosis was increased in MTX-treated animals, while L-Car reversed these effects. Severe degeneration of the intestinal mucosa, liver parenchyma, and glomerular and tubular epithelium observed in the saline-treated MTX group was improved by L-Car treatment. These results suggest that L-Car, possibly via its free radical scavenging and antioxidant properties, ameliorates MTX-induced oxidative organ injury and inhibits leukocyte apoptosis. Thus, supplementation with L-Carnitine as an adjuvant therapy may be promising in alleviating the systemic side-effects of chemotherapeutics.
dc.identifier.doi10.1007/s10565-006-0025-0
dc.identifier.issn0742-2091
dc.identifier.pubmed16463019
dc.identifier.urihttps://hdl.handle.net/11424/228160
dc.identifier.wosWOS:000235139300005
dc.language.isoeng
dc.publisherSPRINGER
dc.relation.ispartofCELL BIOLOGY AND TOXICOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectmethotrexate
dc.subjectmyeloperoxidase
dc.subjectglutathione
dc.subjectTNF-alpha
dc.subjectapoptosis
dc.subjectoxidative injury
dc.subjectACETYL-L-CARNITINE
dc.subjectINDUCED LIPID-PEROXIDATION
dc.subjectL-PROPIONYL-CARNITINE
dc.subjectSMALL-INTESTINE
dc.subjectHEMODIALYSIS-PATIENTS
dc.subjectRENAL-FAILURE
dc.subjectRAT MODEL
dc.subjectHEPATOTOXICITY
dc.subjectINFLAMMATION
dc.subjectGLUTATHIONE
dc.titleL-Carnitine ameliorates methotrexate-induced oxidative organ injury and inhibits leukocyte death
dc.typearticle
dspace.entity.typePublication
local.avesis.id702f7ce9-b9ba-4556-bd48-25b8bde30e68
local.import.packageSS17
local.indexed.atWOS
local.indexed.atSCOPUS
local.indexed.atPUBMED
local.journal.numberofpages14
oaire.citation.endPage60
oaire.citation.issue1
oaire.citation.startPage47
oaire.citation.titleCELL BIOLOGY AND TOXICOLOGY
oaire.citation.volume22
relation.isAuthorOfPublicatione4eaf9ac-f8dc-4e2b-b940-895cc906790d
relation.isAuthorOfPublication.latestForDiscoverye4eaf9ac-f8dc-4e2b-b940-895cc906790d

Files

Collections

Research Outputs